Speaker:

Nicholas Pytel, DO

Hematology/Oncology Fellowship - Pediatrics

UW SMPH 

 

Learning Objectives: 

  1. Determine causes of secondary malignancies after brain tumor treatment
  2. Examine novel compound’s uptake and biodistribution in murine brain tumor model
  3. Analyze murine survival and possible synergistic effects using novel TRT agent for brain tumors

 

 

 

Session date: 
Thursday, May 14, 2020 - 7:30am to 8:30am
Location: 
Health Sciences Learning Center
Via Blackboard Collaborate
WI
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.